Extended-cycle dosing of an ultralow-dose contraceptive vaginal ring decreases the frequency of migraine aura and largely prevents menstrual-related migraine headache, results of a pilot observational study suggest.
Extended-cycle dosing of an ultralow-dose contraceptive vaginal ring decreases the frequency of migraine aura and largely prevents menstrual-related migraine headache, results of a pilot observational study suggest.